A scoping review protocol to elucidate outcomes following abiraterone versus enzalutamide for prostate cancer
HIGHLIGHTS who: Yash B. Shah and collaborators from the Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, United […]